Clinical Trial

Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg

Study acronym: TRIO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 27, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-03.
Trial Details
NCT Number NCT07400926
Lead Sponsor Glaukos Corporation
Conditions Open Angle Glaucoma (OAG), Ocular Hypertension (OH)
Enrollment 30 participants
Start Date 2025-12-17
Primary Completion 2026-06 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-02-27